Growth hormone in short, slowly growing children and those with Turner's syndrome. 1987

C R Buchanan, and C M Law, and R D Milner
Institute of Child Health, London.

Results of an aborted placebo controlled trial of treatment with human pituitary growth hormone in children with Turner's syndrome and short, slowly growing children are reported. One child in each group had a considerable reduction in growth rate standard deviation score while taking growth hormone. The remaining eight patients with Turner's syndrome and 10 short, slowly growing patients who received growth hormone showed mean rises in growth rate of greater than two standard deviation scores. Neither placebo group showed a mean increase in growth rate standard deviation score. These differences were significant.

UI MeSH Term Description Entries
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006128 Growth Gradual increase in the number, the size, and the complexity of cells of an individual. Growth generally results in increase in ORGAN WEIGHT; BODY WEIGHT; and BODY HEIGHT.
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C R Buchanan, and C M Law, and R D Milner
September 1990, Acta endocrinologica,
C R Buchanan, and C M Law, and R D Milner
January 1990, Acta paediatrica Scandinavica. Supplement,
C R Buchanan, and C M Law, and R D Milner
January 1995, Journal of pediatric endocrinology & metabolism : JPEM,
C R Buchanan, and C M Law, and R D Milner
October 1986, The Journal of clinical endocrinology and metabolism,
C R Buchanan, and C M Law, and R D Milner
November 1991, Harefuah,
C R Buchanan, and C M Law, and R D Milner
July 1981, Scottish medical journal,
C R Buchanan, and C M Law, and R D Milner
June 1992, Irish medical journal,
C R Buchanan, and C M Law, and R D Milner
January 1986, Acta paediatrica Scandinavica. Supplement,
C R Buchanan, and C M Law, and R D Milner
March 1968, The Journal of clinical endocrinology and metabolism,
C R Buchanan, and C M Law, and R D Milner
May 1978, The New England journal of medicine,
Copied contents to your clipboard!